Novel Coronavirus (SARS-COV-2) IgG/IgM antibody detection kit was successfully developed by Shuangzh

Shuangzheng medical has successfully developed the Novel coronavirusIgG/IgM antibody detection kit

JiLinShuang is medical technology co., LTD, jilin university Wang Fang translational medicine research institute, mager research team, the latest developed will be coronavirusIgG/IgM antibody rapid detection kit, and has set up a fixed-point hospital of jilin university in changchun COVID 18-19 bao the nations, dew, the first hospital team and changchun Zhang Yi infectious disease hospital, Sun Xuejuan team completed a preliminary evaluation. Now we are actively applying for the green channel for emergency approval of National Medical Products Administration.

Five novel Coronavirus positive cases (RT-PCR nucleic acid test) were tested. The results of BOTH IgM and IgG tests were positive, and the positive coincidence rate was 100%. Through 22 cases of clinical suspected cases, kit and nucleic acid detection results consistent rate was 90.90% (both negative for 20 cases, antibody testing positive for nucleic acid detection results negative 1 case, negative nucleic acid detection result positive antibody detection in 1 case), early results summary analysis and later clinical trials in the strict and orderly.

The kit USES colloidal gold immunochromatography technology to detect human serum, whole blood novel coronavirusIgG/IgM antibody, the fastest can be observed in 15 minutes to obtain the detection results. The efficacy of this kit should be verified clinically with a large sample. After obtaining the registration approval from the National Bureau of Registration, combined testing with nucleic acid will help to improve the detection rate of coronavirus infection from the novel, avoid the "false negative" result, further improve the accuracy of microbiology examination of coronavirus infection from the novel, and provide help for the clinical diagnosis and treatment of coronavirus infection from the novel. The simultaneous detection of IgM and IgG is in line with the recommended strategy of the Clinical Examination Center of the National Health Commission (see related link 1 for details). The two results complement each other, improve the overall accuracy and help to judge the course of disease. In addition, IgG antibody detection is also used in the epidemiological investigation of the epidemic situation.

Compared with rt-pcr nucleic acid detection, the detection method has simple operation, rapid, accurate, to detect and limit the advantages of small, and can complement each other with nucleic acid detection methods, thus shortening the will of coronavirus detection, speed up the COVID - 19 (COVID - 19) the suspected cases of real-time field screening, diagnosis and close contact with people that found that detection and reduce the risk of transmission, especially suitable for the professional inspection personnel shortage and molecular biology used testing equipment lack of grassroots medical institutions.